Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Convertible Preferred Stock and Changes in Stockholders??? (Deficit) Equity (Unaudited)

v3.21.2
Condensed Consolidated Statements of Convertible Preferred Stock and Changes in Stockholders’ (Deficit) Equity (Unaudited) - USD ($)
$ in Thousands
Convertible Preferred Stock
Preferred Stock
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Total
Balance at Dec. 31, 2019 $ 53,882 $ 3,174 $ (68,274) $ (41) $ (65,141)
Balance (in Shares) at Dec. 31, 2019 14,639,043 833,505        
Issuance of Series B convertible preferred stock, net of issuance costs $ 401
Issuance of Series B convertible preferred stock, net of issuance costs (in Shares) 173,752          
Exercise of common stock options 2 2
Exercise of common stock options (in Shares) 1,924        
Stock-based compensation expense 97 97
Foreign currency translation adjustment (1) (1)
Net loss (4,738) (4,738)
Balance at Mar. 31, 2020 $ 54,283 3,273 (73,012) (42) (69,781)
Balance (in Shares) at Mar. 31, 2020 14,812,795 835,429        
Stock-based compensation expense 295 295
Foreign currency translation adjustment (11) (11)
Net loss (2,959) (2,959)
Balance at Jun. 30, 2020 $ 54,283 3,568 (75,971) (53) (72,456)
Balance (in Shares) at Jun. 30, 2020 14,812,795 835,429        
Exercise of common stock options
Exercise of common stock options (in Shares)   606        
Stock-based compensation expense 99 99
Foreign currency translation adjustment 3 3
Net loss (4,116) (4,116)
Balance at Sep. 30, 2020 $ 54,283 3,667 (80,087) (50) (76,470)
Balance (in Shares) at Sep. 30, 2020 14,812,795 836,035        
Balance at Dec. 31, 2020 $ 3 87,051 (83,878) (52) 3,124
Balance (in Shares) at Dec. 31, 2020 26,859,850        
Issuance of common stock warrants 395 395
Issuance of common stock in connection with exercise of warrants 4 4
Issuance of common stock in connection with exercise of warrants (in Shares) 4,208        
Stock-based compensation expense 384 384
Foreign currency translation adjustment 4 4
Net loss (4,904) (4,904)
Balance at Mar. 31, 2021 $ 3 87,834 (88,782) (48) (993)
Balance (in Shares) at Mar. 31, 2021 26,864,058        
Issuance of common stock to service provider 600 600
Issuance of common stock to service provider (in Shares)   120,000        
Exercise of common stock options 100 100
Exercise of common stock options (in Shares)   126,876        
Stock-based compensation expense 239 239
Foreign currency translation adjustment (1) (1)
Net loss (4,637) (4,637)
Balance at Jun. 30, 2021 $ 3 88,773 (93,419) (49) (4,692)
Balance (in Shares) at Jun. 30, 2021   27,110,934        
Exercise of common stock options 13 13
Exercise of common stock options (in Shares)   23,351        
Stock-based compensation expense 371 371
Foreign currency translation adjustment 3 3
Net loss (2,859) (2,859)
Balance at Sep. 30, 2021 $ 3 $ 89,157 $ (96,278) $ (46) $ (7,164)
Balance (in Shares) at Sep. 30, 2021   27,134,285